This is a multicenter single-arm, open-label, phase II study with a two-stage design conducted in 12 Spanish GELTAMO sites (ClinicalTrials.gov identifier: NCT02682641). Previously untreated MCL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback